Abnormal phosphorylation / dephosphorylation and Ca²⁺ dysfunction in heart failure

Area of Science:

• Cardiology
• Molecular Biology
• Biochemistry

Background:

• Heart failure (HF) is characterized by impaired myocardial systole and diastole.
• Calcium (Ca2+) influx via L-type calcium channels (LTCC) initiates the cardiac cycle.
• HF involves myocardial Ca2+ handling dysfunction, linked to altered protein phosphorylation/dephosphorylation.

Purpose of the Study:

• To review phosphorylation/dephosphorylation changes in HF progression.
• To summarize effects on LTCC, ER, and myofilament function in normal and failing hearts.
• To discuss current and potential therapeutic strategies targeting abnormal phosphorylation.

Main Methods:

• Literature review of experimental and clinical research.
• Analysis of phosphorylation/dephosphorylation patterns in HF.
• Synthesis of data on LTCC, ER, and myofilament regulation.

Main Results:

• HF is associated with unbalanced phosphorylation/dephosphorylation of LTCC, ER, and myofilaments.
• Kinase and phosphatase activities shift during HF progression, altering phosphorylation states.
• Significant differences exist in phosphorylation profiles between normal and failing hearts.

Conclusions:

• Phosphorylation/dephosphorylation dynamics are critical in HF pathogenesis.
• Understanding these changes offers insights into HF mechanisms.
• Targeting abnormal phosphorylation presents a promising therapeutic avenue for HF.